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Transformation of atrioventricular (AV) canal endocardium into invasive mesenchyme correlates spatially and temporally with the expression
of bone morphogenetic protein (BMP)-2 in the AV myocardium. We revealed the presence of mRNA of Type I BMP receptors, BMPR-1A
(ALK3), BMPR-1B (ALK6) and ALK2 in chick AV endocardium at stage-14−, the onset of epithelial to mesenchymal transformation (EMT), by
RT–PCR and localized BMPR-1B mRNA in the endocardium by in situ hybridization. To circumvent the functional redundancies among the Type
I BMP receptors, we applied dominant-negative (dn) BMPR-1B-viruses to chick AV explants and whole-chick embryo cultures to specifically
block BMP signaling in AV endocardium during EMT. dnBMPR-1B-virus infection of AV endocardial cells abolished BMP-2-supported AV
endocardial EMT. Conversely, caBMPR-1B-virus infection promoted AV endocardial EMT in the absence of AV myocardium. Moreover,
dnBMPR-1B-virus treatments significantly reduced myocardially supported EMT in AV endocardial–myocardial co-culture. AV cushion
mesenchymal cell markers, α-smooth muscle actin (SMA), and TGFβ3 in the endocardial cells were promoted by caBMPR-1B and reduced by
dnBMPR-1B infection. Microinjection of the virus into the cardiac jelly in the AV canal at stage-13 in vivo (ovo) revealed that the dnBMPR-1B-
virus-infected cells remained in the endocardial epithelium, whereas caBMPR-1B-infected cells invaded deep into the cushions. These results
provide evidence that BMP signaling through the AV endocardium is required for the EMT and the activation of the BMP receptor in the
endocardium can promote AV EMT in the chick.
© 2007 Elsevier Inc. All rights reserved.Keywords: Bone morphogenetic protein receptor; Heart; Atrioventricular cushion; Retroviral gene transfer; Epithelial–mesenchymal transformationIntroduction
Valvuloseptal morphogenesis of the primitive heart tube into
a four-chambered organ requires the formation of the
endocardial cushion tissue in two segments of the primary
heart tube, the atrioventricular (AV) canal and the conus/truncus
outlet (OT) (reviews: Eisenberg and Markwald, 1995; Mark-
wald et al., 1996; Nakajima et al., 2000; Person et al., 2005). In
the AV canal, transformation of endocardial endothelial cells
into invasive mesenchymal cells plays a critical role in cushion
tissue formation and this transformation correlates spatially and⁎ Corresponding author. Fax: +1 843 792 0664.
E-mail address: sugiy@musc.edu (Y. Sugi).
1 Present address: Department of Pediatrics, Shakaihoken Shiga Hospital,
Fujimidai 16-1, Otsu-city, Shiga 520-0846, Japan.
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.03.015temporally with the expression of bone morphogenetic protein-
2 (BMP-2) in the AV myocardium (Lyons et al., 1990; Jones et
al., 1991; Yamada et al., 1999; Yamagishi et al., 1999; Somi et
al., 2004; Sugi et al., 2004). BMPs, a subgroup of the
transforming growth factor (TGF)-β super-family, are well
implicated in embryonic development (Francis-West et al.,
1994; Wall and Hogan, 1995; Hogan, 1996). However, early
lethality of conventional BMP-2- (Zhang and Bradley, 1996),
BMPR-1A- (Mishina et al., 1995) or BMPR-II- (Beppu et al.,
2000) deficient mice significantly hampered addressing the role
of BMPs in AV EMT. Using in vitro culture assays, we were
able to show that BMP-2 was sufficient and BMP-signaling was
required for AV EMT in mice (Sugi et al., 2004). More recently,
conditional deletion of BMP-2 using the NKx2.5-cre system
confirmed that myocardially derived BMP-2 was essential for
AV endocardial transformation into cushion mesenchyme in
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2 was also implicated in AV canal morphogenesis in chick
(Yamagishi et al., 1999; Romano and Runyan, 2000). However,
expression of BMP receptors in AV endocardium and the
functional roles of these receptors in AV EMT remained to be
elucidated.
BMPs exert their biological function by interacting with
cell surface receptors. BMP receptors consist of Type-1 and
Type-2 receptors and both types of receptors contain
intracellular serine/threonine kinase domains, which are
required for signal transduction. Type-2 receptors transpho-
sphorylate the glycine–serine-rich domain (GS domain) of
Type-1 receptors, which induce activation of the Type-1
receptor and transduce signals (Hogan, 1996; Yamashita et al.,
1996; de Caestecker, 2004). BMP type 1 receptors are
classified into subtypes, activin-receptor-like kinase-1,
(ALK)-1/TTSR-I, activin Type I receptor, (ACTRI)/ALK2,
ALK3/BMPR-1A, and ALK6/BMPR-1B (Hogan, 1996; Yama-
shita et al., 1996; Yi et al., 2000). Most of the BMP receptors
have ligand binding affinity with other TGFβ super family
proteins, i.e. TGFβs and activin (Yamashita et al., 1996; de
Caestecker, 2004). However, BMPR1-A (ALK3) and BMPR1-
B (ALK6) bind specifically with BMP-2 and BMP-4, and bind
with BMP-7 at low affinity but do not bind with TGFβs or
activin (Dijke et al., 1994; Raftery and Sutherland, 1999; de
Caestecker, 2004).Fig. 1. Expression of type 1 BMP receptors by chick embryo heart. (A) Messenger R
were reverse-transcribed and cDNA samples were subjected to PCR to amplify cDNA
(lanes 3, 5, and 7) transcripts were detected at stage-14− (lanes 2 and 3) and -18 (lanes
from a reaction performed on RNA from the stage-18 chick embryo heart. The PCR
and 1-kbp ladder size markers, respectively. (B–D) Localization of BMPR-1BmRNA
treatment as a negative control. (C) Antisense probe treatment revealed BMPR-1B e
arches. (D) Endocardial expression of BMPR1-B was detected in a higher magnifica
from stage-14− endocardium. Arrows in panels B and C, hearts. Arrows in panel DIn this work, we detected transcripts of BMPR-1A (ALK 3),
BMPR-1B (ALK 6), and ALK2 in AV endocardial cells at
stage-14−, at the onset of AV EMT by RT–PCR and localized
BMPR-1B in endocardium in stage-14−/15 chick embryos.
Because multiple BMP receptors are expressed in the
endocardium, we sought to address the role of BMP signaling
in the AV endocardium using a dominant-negative approach to
circumvent functional redundancies. We over expressed dn- or
ca-BMPR-1B using RCAS (avian leukemia virus long terminal
repeat with splice acceptor)-based viral constructs to specifi-
cally perturb or actively transduce the BMP signaling in chick
AV explants and whole-embryo cultures. A significance of the
virally supported gene transfer technique is that we can alter the
signaling in a spatio-temporally specific manner coincident with
AV canal morphogenesis without affecting the growth of other
parts of the embryos. Moreover, RCAS virus-infected cells,
both in culture and in vivo (ovo), could be visually detected
using antibodies to RCAS viral protein to make direct
comparison of infected- and non-infected cells in the same
biological condition.
Our findings provide evidence that BMP signaling through
AV endocardial endothelial cells is required for AV EMT and
that the activation of the BMP receptor in endocardial cells
promotes AV cushion mesenchymal cell formation in the chick.
This work was partially reported in an abstract form (Okagawa
et al., 2000).NAwas extracted from stage-14− and -18 chick embryo hearts. Extracted RNAs
of BMPR-1A and BMPR-1B. Both BMPR-1A (lanes 2, 4, and 6) and BMPR-1B
4 and 5). For the PCR controls (lanes 6 and 7), reverse transcriptase was omitted
products were separated on a 1.1% agarose gel. Lanes 1 and 8 contained 100-bp
by whole-mount in situ hybridization of stage-14 chick embryo. (B) Sense probe
xpression in the heart. BMPR-1B was also detected in somites and pharyngeal
tion picture. (E) Transcripts of BMP-R1A, BMPR-1B and ALK-2 were detected
, endocardium.
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Chick embryos
Viral-free fertilized eggs of White Leghorn (Gallus gallus domesticus)
chicken were purchased from SPAFAS (Preston, CN) and incubated in a humid
atmosphere at 37.5 °C. Stages of embryonic development were determined by
using the criteria of Hamburger and Hamilton (1951).
Detection of Type I BMP receptor expression from chick heart by
RT–PCR
RT–PCR analysis of BMPR-1A, BMPR-1B, and ALK2 was performed
based on the methods described previously (Sugi and Markwald, 2003).Fig. 2. AVendocardial monolayer cultured with M199 alone (A and B), BMP-2 (C and
2+noggin (I and J) on hydrated collagen gels. (A, C, E, G and I) surface view. (B, D
monolayer was explanted from stage-14− chick embryos and cultured for 48 h. When
formation was not detected (A and B). In contrast, BMP-2-treated explants formed i
(I and J), invasive mesenchymal cell formation was largely inhibited by adding dnB
caBMPR-1B exhibited larger number of invasive mesenchymal cells within the collBriefly, total RNA was isolated and purified from chick hearts from
Hamburger and Hamilton (1951) stage-14− and -18 chick embryos and stage-
14− endocardium using the RNAzol method (Chomczynski and Sacchi, 1987;
TEL-TEST, Inc.). AV endocardium was prepared by culturing stage-14− AV
canal, facing endocardial-side down to the fibronectin (20 μg/ml, Sigma)-
coated culture wells and by removing myocardium in 4 h. Complementary
DNA was prepared by using oligo-dT (Promega) primed M-MLV reverse
transcriptase (Promega). The cDNA was amplified using Thermus aquaticus
(Taq) DNA polymerase (Promega). Primers (Invitrogen) for whole hearts
were designed for BMPR-1A (forward, 5′-CAAGCACTATTGTAAGT-
CAATG-3′, reverse, 5′-TCAAATCTTTACATCTTGTGAT-3′), BMPR-1B
(forward, 5′-TGCTACTTCAGGTATAAGCGGC-3′, reverse 5′-TTAGAGCT-
TAATGTCCTGCGAC-3′). Primers for stage-14− AV endocardium were
designed for BMPR-1A (forward, 5′-CTGAGAGTTGAGCGATTG-3′,
reverse, 5′-CAGCCAGAAGCAAGTGTTGG-3′), BMPR-1B (forward, 5′-D), BMP-2+dnBMPR-1B (E and F), BMP-2+caBMPR-1B (G and H) or BMP-
, F, H and J) deep view (−80 μm from the surface of the gel). AV endocardial
endocardial monolayer was cultured in M199 alone, invasive mesenchymal cell
nvasive mesenchymal cells (arrows in panel D). Similar to the effect of noggin
MPR-1B to BMP-2 (E and F). Conversely, AV monolayer cultured in BMP-2+
agen gel (arrows in panel H). Scale bar=100 μm.
Fig. 3. Quantitative evaluation of invasive mesenchymal cell formation from AV
endocardial monolayer treated with M199 alone, BMP-2, BMP-2+dnBMPR-
1B, BMP-2+caBMPR-1B or BMP-2+noggin. BMP-2 supported mesenchymal
cell formation was significantly inhibited in noggin- (*p<0.001 by Student's
t-test) or dnBMPR-1B- (*p<0.001 by Student's t-test) treated explants and
was enhanced in caBMPR-1B- (**p<0.03 by Student's t-test) treated explants.
Number of explants evaluated for each treatment: 24 for M199 alone, 16 for
BMP-2, 20 for BMP-2+dnBMPR-1B, 21 for BMP-2+caBMPR-1B and 8 for
noggin. N=number of areas counted in each explant.
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TAGGAGTGTCC-3′) and ALK2 (forward, 5′-CTGTGTTGGGGTCACTG-3′,
reverse, 5′-TGGAAGCAGCCTTTCTGG-3′). Sequence information was fromFig. 4. AV endocardial monolayer treated with BMP-2+dnBMPR-1B, BMP-2+caBM
AMV3c2 (A, D, and G) and a mesenchymal marker, anti-α-SMA (B, E, and H) or ant
the explants. Panels C, F, and I depict different areas of the same explants. These pictu
as α-SMA-negative TGFβ3-negative endocardial epithelial cells (A–C), whereas, caB
mesenchymal cells (D–F). Panels G–I are explants not infected with the virus but cult
and anti-TGFβ3. Scale bar=100 μm.GenBank and accession numbers are L49204 for BMPR-1A, D13432 for
BMPR-1B, and U38622 for ALK2, respectively. That the predicted PCR
products were not amplified from genomic DNA was verified by treating
samples with RNase-free DNase-1 (Promega) before RT. As a negative control,
the RT step was omitted. The PCR products were verified by thermal cycle
sequencing using Taq DNA polymerase and fluorescent dye-labeled termina-
tions (Medical University of South Carolina, Biotechnology Resource
Laboratory).
In situ hybridization
Digoxigenin-labeled, single-stranded RNA was generated using the DIG
RNA labeling kit (Roche) according to manufacturer's instructions. A chick
BMPR1-B cDNA cloned into pBluescript II SK (+) (kindly provided by Dr. T.
Nohno, Okayama, Japan) was linearized using EcoRI for the sense probe or
BamHI for the antisense probe. T3 RNA polymerase or T7 RNA polymerase
was used to construct the sense or antisense probe, respectively.
For whole-mount preparation, chick embryos from stages 8 to 18 were
collected and fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS)
and processed for whole mount in situ hybridization. After the treatment of
proteinase K (Roche) and rinsing in PBS–Tween 20, samples were treated with
hybridization buffer for prehybridization for 2–4 h then hybridized with a
digoxigenin-labeled probe (0.2 μg/ml) in the hybridization buffer at 65 °C
overnight. After rinsing, samples were treated for immunohistochemical
detection of digoxigenin by using alkaline phosphatase-conjugated sheep anti-
digoxigenin Fab fragment (Roche) and signals were detected by nitroblue
tetrazolium chloride (NBT)/5-bromo-4-chloro-3-indolyl phosphate, toluidine
salt (BCIP) (Roche).
In situ hybridization of tissue sections was performed as previously
described (Somi et al., 2004) with the following modifications. Paraformalde-
hyde-fixed stage-10 to -18 chick embryos were embedded in paraffin and 10-μm
sections were cut and processed through 20 μg/ml proteinase K (Ambion)/PBSPR-1B or M199 alone were double immunostained with a RCAS viral marker,
i-TGFβ3 (C, F, and I). Panels A and B, D and E, G and H depict the same area of
res indicate that dnBMPR-1B-infected cells tend to stay on the surface of the gel
MPR-1B-infected cells tend to become invasive SMA-positive, TGFβ3-positive
ured with M199 alone, which shows negative staining for AMV3c2, anti-α-SMA
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Dig-labeled riboprobe at 70 °C overnight. Color reactions using NBT/BCIP
were allowed to develop for 48–72 h at room temperature.
Generation and propagation of retrovirus
Two mutant constructs of chick BMPR-1B cloned into the replication-
competent avian retroviral vector RCAS-(A) (Hughes et al., 1987) were kindly
provided by Dr. L. Niswander (Howard HughesMedical Institute and University
of Colorado Health Sciences Center–Fitzsimmons Campus Denver, CO). The
dominant-negative form (dnBMPR-1B) blocks BMP signaling pathways by a
single amino acid substitution (Lys-231 to Arg) within the adenosine
triphosphate binding site in the kinase domain. Because dnBMPR-1B lacks the
activity of an intracellular kinase domain, dnBMPR-1B expressed at the cell
surface can bind BMPs but does not transmit signals. The constitutively active
form (caBMPR-1B) has a single amino acid substitution (Gln-203 to Asp) within
the GS activation domain. caBMPR-1B is activated constitutively and transmits
signals without BMP binding. dnBMPR-1B and caBMPR-1B viruses were
previously constructed and blocked and activated BMP signaling, respectively, in
avian embryonic tissue cultures (Zou and Niswander, 1996; Zou et al., 1997).
Primary fibroblasts cells were collected from day-10 chick embryos and
transfected with retroviral constructs with FuGENE 6-transfection reagent
(Roche). Supernatant from the transfected cultures was collected and
concentrated by ultracentrifugation. Concentrated virus was resuspended in
M199 (Invitrogen) and stored at −80 °C. The viral titer was measured with
immunohistochemical detection of viral protein p19 by monoclonal antibody,Fig. 5. AVendocardial/myocardial co-culture treated with dnBMPR-1B, caBMPR-1B
from the surface) within the gel. AV explants from stage-14− embryos were cultured
caBMPR-1B (E and F) or noggin (500 ng/ml) (G and H) for 48 h. Explants treated wi
explants cultured in M199 alone (A and B). Conversely, similar to the effect of no
collagen gel (C and D). m, myocardium. arrows, invasive mesenchymal cells. ScaleAMV3c2 (Developmental Studies Hybridoma Bank) using virus-infected
fibroblast culture. A viral titer (2–5×109–10 active virion/ml) was constantly
achieved after ultracentrifugation of the viral supernatant.
AV explant culture
The culturing procedure was described previously (Bernanke andMarkwald,
1982; Runyan and Markwald, 1983; Ramsdell and Markwald, 1997). Briefly,
AV explants from stage-14− chick embryo hearts were placed on the hydrated
collagen gels (rat tail tendon collagen, 1.0 mg/ml, Collaborative Research),
equilibrated in medium (M 199, Invitrogen), supplemented with 1% chick serum
(Sigma) and ITS (5 μg/ml insulin, 5 μg/ml transferrin, and 5 ng/ml selenium,
Collaborative Research), and antibiotics (100 units/ml penicillin and 100 μg/ml
streptomycin, Invitrogen). For AVendocardial endothelial culture, myocardium
was removed 4 h after placement of the explants on the collagen gel.
Recombinant human noggin (kindly provided by Regeneron Pharmaceuticals,
Inc., NY; final concentration, 500 ng/ml), BMP-2 (kindly provided by Genetics
Institute, MA; final concentration, 200 ng/ml), and dnBMPR-1B or caBMPR-
1B-RCAS virus (final concentration, 1.5×108 virion/ml) were added alone or in
combination with BMP-2 to the culture 4 h after the placement of the explants
onto the gel. For some experiments, endocardium was co-cultured with
associated myocardium and was infected with dnBMPR-1B or caBMPR-1B, or
treated with noggin. Cultures were observed daily under an inverted microscope
(Olympus, IMT-2). For the index of mesenchymal cell formation, cells on the
surface and at −80-μm deep from the surface of the collagen gel were counted
after 48 h of culture., or noggin. (A, C, E, and G) surface view. (B, D, F and H) deep view (−80 μm
in medium 199 (M199) alone (A and B), M199 with dnBMPR-1B (C and D),
th caBMPR-1B formed more invasive mesenchymal cells (E and F) than control
ggin (G and H), when cultured with dnBMPR-1B, fewer cells invaded into the
bar=100 μm.
Fig. 6. Quantitative evaluation of invasive mesenchymal cell formation from AV
endocardial/myocardial co-culture treated with dnBMPR-1B, caBMPR-1B, or
noggin. Mesenchymal cell formation was significantly inhibited in noggin- or
dnBMPR-1B-treated explants and enhanced in caBMPR-1B-treated explants
(*p<0.005 by Student's t-test). Number of explants tested for each treatment: 15
for M199-treated, 19 for dnBMPR-1B-treated, 22 for caBMPR-1B-treated and
11 for Noggin-treated. N=number of areas counted in each explant.
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Cultured explants were double-immunostained with a combination of
AMV3c2 and anti-α-SMA (Sigma), anti-TGFβ3 (Santa Cruz) and anti-α-SMA,
or AMV3c2 and anti-TGFβ3 depending on the experimental necessity.
AMV3c2 recognizes RCAS viral protein, and α-SMA has been used as a
marker for AV cushion mesenchymal cell formation in the chick (Nakajima et
al., 1997). The specificity of the anti-TGFβ3 was previously tested by
immunopreabsorption using chick AV cushion tissues (Ramsdell andMarkwald,
1997). After a 48-h culture, explants were fixed with 4% paraformaldehyde and
subsequently rinsed with 1.5% Tween/PBS (PBST), blocked with 10% normal
goat serum (ICN) and incubated with primary antibody, AMV3c2. Immune
complexes were detected with FITC-conjugated goat anti-mouse IgG (ICN). For
double-immunostaining with anti-TGFβ3 and anti-α-SMA, explants were fixed
with 100% methanol at −20 °C and treated for immunostaining as described
above. For double-immunostaining with anti-TGFβ3 and AMV3c2, samples
were processed for AMV3c2 immunostaining as described above and stained
with anti-TGFβ3. Immunostained samples were observed under a confocal
microscope, Bio-Rad MRC-1000 Laser Scanning Confocal Imaging System
equipped with a Zeiss Axioskop.
TGFβ3 immunointensity in cells
Detection of immunointensity was described previously (Sugi et al., 2004).
Briefly, original photographs were taken under a laser confocal microscope (Bio-
Rad MCR-1000) equipped with a Zeiss Axioskop. For each sample, the same
condenser iris opening (4.0) and 30% laser was applied. TGFβ3 immunointen-
sity was evaluated by measuring the intensity of TGFβ3 immunofluorescence of
the cells in the photograph using the computer software, Adobe Photoshop 5.5
(Adobe System, Inc.). AMV3c2 positive endocardial epithelial cells or
mesenchymal cells were analyzed to obtain the average intensity of TGFβ3
immunofluorescence for each viral treatment. The average fluorescent intensity
of endocardial epithelial cells cultured with M199 alone was used as a control for
TGFβ3 immunointensity.
Microinjection
Fertilized chicken eggs were incubated in a humid atmosphere at 37.5 °C,
windowed, and carefully staged. A volume (1–5 nl) of dnBMPR-1B or
caBMPR-1B-virus solution (viral titer, 2–5×109 active virion/ml) containing
Polybrene (100 μg/ml) was pressure injected into cardiac jelly near the
endocardial side of AV canal in stage-13 chick embryos in ovo with a
microinjector apparatus, the Picospritzer II pressure system (Parker, NJ), which
was equipped with three-dimensional manipulators, MMN-1 and MMO-
220ND (Narishige, Japan), and one-dimensional micromanipulator, MMO-220
(Narishige, Japan). Eggs were resealed and incubated for an additional two
days. Embryos were fixed with 4% paraformaldehyde and processed for
AMV3c2-immunostaining followed by FITC-conjugated secondary antibody
detection. Virally infected cells in the AV canal were detected under a confocal
microscope (Bio-Rad MRC-1000, Laser Scanning Confocal Imaging System
equipped with a Zeiss Axioskop). Some embryos were embedded in paraffin
(Paraplast X-TRA) and processed for sectioning at 6 μm.
Results
Expression of Type I BMP receptors by chick AV endocardium
RT–PCR analysis revealed mRNA-expression of BMPR-1A
and BMPR-1B from stage-14− and -18 chick embryonic hearts
(Fig. 1A). BMPR-1A, BMPR-1B, and ALK2 were detected from
cultured stage-14− AV endocardium (Fig. 1E).
BMPR-1B mRNA was localized by whole-mount in situ
hybridization in stage-14 chick embryos. BMPR-1BmRNAwas
expressed in endocardium (arrows in Figs. 1C, D) and somites
(Fig. 1C). BMPR-1B was also expressed in branchial arches andthe neuroepithelial wall of the ventricle in the brain (not shown).
Although endocardial expression was low, its expression was
consistent with the RT–PCR data shown above. Restriction of
BMPR-1B to the AV or OT region was not clearly detected
(Figs. 1C, D). Section in situ hybridization also revealed
BMPR-1B expression in the endocardium. However, there was
no clear restriction of the BMPR-1B to the cushion forming
segments of in the heart (not shown).
AV endocardial endothelium was cultured on collagen gels to
assess the effect of dnBMPR-1B, caBMPR-1B, or noggin under
treatment of BMP-2
AV endocardial epithelial monolayers were explanted from
stage-14− chick embryos. When AV endocardial monolayers
were cultured in M199 alone in the absence of myocardium,
epithelial monolayers extended on the surface of the collagen
gels (Fig. 2A) but invasive mesenchymal cells were not
detected (Figs. 2B and 3) as previously reported (Krug et al.,
1985; Mjaatvedt et al., 1987; Nakajima et al., 1994; Ramsdell
and Markwald, 1997). In contrast, when endocardial epithelial
monolayers were cultured with BMP-2 in M199, the explants
formed invasive mesenchymal cells within 48 h (Figs. 2D and
3). BMP-2-supported mesenchymal cell formation was largely
inhibited by adding dnBMPR-1B virus to the culture (Figs.
2E, F and 3) similar to the effect of noggin, an antagonist to
BMP-2/4 (Zimmerman et al., 1996) (Figs. 2I, J and 3).
Conversely, when AV endocardial epithelial monolayers were
treated with BMP-2+caBMPR-1B they exhibited a larger
number of invasive mesenchymal cells within the collagen gel
(Figs. 2H and 3).
Cultured AV endothelial monolayers were further evaluated
for the expression of mesenchymal markers. The explants were
double immunostained with a virus marker, AMV3c2 and
185H. Okagawa et al. / Developmental Biology 306 (2007) 179–192mesenchymal cell markers, anti-α-SMA and anti-TGFβ3.
TGFβ3 has been used as a chick cardiac cushion mesenchymal
cell marker (Nakajima et al., 1997). In the AV endocardial
monolayers treated with BMP-2+dnBMPR-1B, most of the
endocardial epithelial cells were positive for AMV3c2 (Fig. 4A)
but not with α-SMA (Fig. 4B) or TGFβ3 (Fig. 4C). Whereas
many mesenchymal cells stained with AMV3c2 expressed α-
SMA and TGFβ-3 in AV endocardial explants treated with
BMP-2+caBMPR-1B (Figs. 4D–F). These results indicated that
dnBMPR-1B-infected cells remained on the surface of the gel as
α-SMA-negative endocardial epithelial cells, whereas,
caBMPR-1B-infected cells became α-SMA-positive, TGFβ3-
positive mesenchymal cells. Taken together, our findingsFig. 7. AVendocardial/myocardial co-culture treated with dnBMPR-1B or caBMPR-1B
G) and a mesenchymal marker, anti-α-SMA (B, D, F, and H). dnBMPR-1B-infected
epithelial cells (arrows in panels A and B). Whereas many dnBMPR-1B-non-infec
caBMPR-1B-infected cells tended to become invasive SMA-positive mesenchymal c
as α-SMA-negative epithelial cells (arrowheads in panels E and F). Scale bar=100indicated that dominant-negative BMPR-1B perturbed/inhibited
BMP-2-supported AV EMT, whereas active BMPR-1B pro-
moted EMT in the chick AV endocardial monolayer.
AV endocardial epithelium was co-cultured with myocardium
on collagen gels to assess the effect of dnBMPR-1B,
caBMPR-1B, or noggin
AV endocardium from stage-14− chick embryos was co-
cultured with associated myocardium on the collagen gels.
After 48 h in co-culture with M199 alone, endothelial
monolayers extended on the surface of the collagen gels (Fig.
5A) and invasive mesenchymal cells were formed (Figs. 5Bwere double immunostained with a RCAS viral marker, AMV3c2 (A, C, E, and
cells tended to stay on the surface of the gel as α-SMA-negative endocardial
ted cells transformed and expressed α-SMA (arrowheads in panels C and D).
ells (arrows in panels G and H), while caBMPR-1B-non-infected cells remained
μm.
Fig. 8. Quantitative evaluation of invasive mesenchymal cell formation in AV
endocardial/myocardial co-culture treated with dnBMPR-1B or caBMPR-1B
(Fig. 7). An infection ratio (%) was calculated from the AMV3c2-positive cell
number/total cell number of surface endocardial endothelial cells (Endo) or
mesenchymal cells (Mes) in dnBMPR-1B- or caBMPR-1B-treated explants,
respectively. For endocardial endothelial cells, dnBMPR-1B-infected cells
occupied a significantly larger portion than caBMPR-1B-infected cells
(*p<0.002 by Student's t-test). Conversely, for mesenchymal cells, caBMPR-
1B-infected cells occupied a significantly larger portion than dnBMPR-1B-
infected cells (*p<0.002 by Student's t-test). N=number of the areas counted.
Fig. 9. Quantitative evaluation and schematic illustration of mesenchymal cell
formation in endocardial/myocardial co-culture treated with dnBMPR-1B or
caBMPR-1B. dnBMPR-1B-treated explants formed significantly fewer
mesenchymal cells in comparison with caBMPR-1B-treated explants. If virus-
infected (AMV3c2-positive) cells were specifically compared, the difference
between dnBMPR-1B-infected explants and caBMPR-1B-infected explants was
more prominent in mesenchymal cell formation. This diagram shows that
dnBMPR-1B significantly reduced mesenchymal cell formation from AV
endocardial/myocardial co-culture. N=number of explants.
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al., 1994; Mjaatvedt et al., 1987; Ramsdell and Markwald,
1997). When explants were treated with dnBMPR-1B, endo-
cardial monolayers also grew on the surface of the collagen gels
(Fig. 5C) but significantly fewer invasive mesenchymal cells
were formed (Figs. 5D and 6) similar to the effect of noggin
treatments (Figs. 5G, H, and 6). In contrast, AVexplants treated
with caBMPR-1B formed more invasive mesenchymal cells
(Figs. 5F and 6) than control explants cultured in M199 alone
(Fig. 5B).
To evaluate mesenchymal marker expression in AV endo-
cardial explants co-cultured withmyocardium, the explants were
double immunostained with AMV3c2, a virus marker, and anti-
α-SMA, a mesenchymal cell marker. Regardless of which types
of viruses infected the cells, when mesenchymal cells were
formed, α-SMA was detected in all mesenchymal cells (Figs.
7D, H) but not in endocardial epithelial cells (Figs. 7B, F). Many
endocardial epithelial cells in explants treated with dnBMPR-1B
were AMV3c2-positive (Figs. 7A and 8) whereas significantly
fewer mesenchymal cells were AMV3c2-positive, indicating
that the majority of dnBMPR-1B-infected endocardial cells
remained epithelial and stayed on the surface of the collagen gels
(Figs. 7C and 8). Fewer number of endocardial epithelial cells in
the explants treated with caBMPR-1B showed AMV3c2 staining
(Figs. 7E and 8), whereas larger numbers of mesenchymal cells
exhibited AMV3c2 staining (Figs. 7G and 8), indicating that a
majority of caBMPR-1B virus-infected cells transformed into
mesenchymal cells and invaded into collagen gels.
Viruses can infect cells at the surface of the explants directly
exposed to the viral solution but cannot penetrate deeper into
the tissue mass. Thus, dnBMPR-1B and caBMPR-1B viruses do
not infect as many endocardial epithelial cells in co-cultured
explants as seen in endocardial monolayer cultures. Therefore,to assess the differences in the effects of caBMPR-1B and
dnBMPR-1B infection in mesenchymal cell formation, the
infection ratio of the invasive mesenchymal cells was compared
in the caBMPR-1B-infected and dnBMPR-1B-infected AV
explants co-cultured with myocardium. As seen in Fig. 9,
there was a statistically significant tendency for dnBMPR-1B-
infected cells to remain on the surface of the gel as α-SMA-
negative endocardial epithelial cells, while caBMPR-1B-
infected cells transformed into α-SMA-positive invasive
mesenchymal cells (also see scheme in Fig. 15). Although
viruses can infect surface of the myocardium in co-cultured
explants, it is less likely that the effects seen with dn- and
caBMPR-1B virus-infection were largely affected by viral
infection of the myocardium because we were able to
immunohistochemically identify AMV3c2-positive cells and
directly compared virus-infected endocardial cells with non-
infected cells in the same explant.
In AVendocardial monolayer explants TGFβ3 was expressed in
mesenchymal cells induced by BMP-2 or BMP-2+caBMPR-1B
but not expressed in endocardial epithelial cells treated with
BMP-2+dnBMPR-1B or M199 alone
When AVexplants were cultured with dnBMPR-1B+BMP-2
in the absence of myocardium, an endocardial monolayer grew
on the surface of the collagen gels but few invasive
mesenchymal cells were formed. Double immunolabeling of
anti-TGFβ3 and anti-α-SMA showed that endocardial epithelial
cells expressed little TGFβ3 (Fig. 10A) or α-SMA (Fig. 10B).
Whereas, when explant was cultured with BMP-2 alone in the
absence of myocardium, endocardial epithelial cells did not
express TGFβ3 or α-SMA (asterisks in Figs. 10E, F) but many
mesenchymal cells expressed TGFβ3 and α-SMA (arrows in
187H. Okagawa et al. / Developmental Biology 306 (2007) 179–192Figs. 10E, F). When cultured with caBMPR-1B+BMP-2, many
invasive mesenchymal cells were formed and expressed both
TGFβ3 (Fig. 10C) and α-SMA (Fig. 10D). When explants were
cultured with control medium M199 alone, only endocardial
monolayers were formed and little, if any, expression of TGFβ3
(Fig. 10G) and α-SMAwas detected (Fig. 10H).
In AV endocardial/myocardial co-culture, TGFβ3 expression
was suppressed in dnBMPR-1B-infected endocardial cells
but enhanced in caBMPR-1B-infected endocardial epithelial
cells
To address the relationship between BMP signaling and
other known endocardially derived mesenchymal cell inducers,
such as TGFβs (Potts and Runyan, 1989; Potts et al., 1991;
Nakajima et al., 1994, 1998; Ramsdell and Markwald, 1997) in
AV cushion formation, AVexplants co-cultured withmyocardiumFig. 10. AVendocardial monolayer treated with BMP-2+dnBMPR-1B, BMP-2+caB
(A, C, E, and G) and a mesenchymal marker, anti-α-SMA (B, D, F, and H). Endoc
express TGFβ3 (A) or α-SMA (B). Whereas, when explants were cultured with
expressed both TGFβ3 (C) and α-SMA (D), similar to the explants treated with BM
negative, α-SMA-negative endothelial cells, but not invasive mesenchymal cells w
cells. Arrows indicate mesenchymal cells which express TGFβ3 and α-SMA. Scaland infected with dnBMPR-1B or caBMPR-1B were double
immunostained with AMV3c2, a virus marker, and anti-TGFβ3.
dnBMPR-1B-infected cells tended to stay on the surface of the gel
as TGFβ3-negative endocardial epithelial cells (arrowheads in
Figs. 11A–C and 12). Conversely, caBMPR-1B-infected cells
tended to become TGFβ3-positive endocardial epithelial cells or
invasive TGFβ3-positive mesenchymal cells (arrows in Figs.
11D–F and 12). Some of the endocardial cells infected with
caBMPR-1B appeared to express TGFβ3 when they were on the
surface of the gels, before they transformed into invasive
mesenchymal cells (arrowheads in Figs. 11D–F). There were
statistically significant differences in TGFβ3 immunointensity
between dnBMPR-1B-infected and caBMPR-1B-infected endo-
cardial endothelial cells (Fig. 12). However, when dnBMPR-1B
infection did not completely block TGFβ3 expression, cells
appeared to transform into mesenchymal cells and express
TGFβ3 (arrows in Figs. 11A–C).MPR-1B, BMP-2 or M199 alone were double immunostained with anti-TGFβ3
ardial epithelial cells in the explants treated with BMP-2+dnBMPR-1B did not
caBMPR-1B+BMP-2, many invasive mesenchymal cells were formed and
P-2 alone (E and F). When explants were cultured with M199 alone, TGFβ3-
ere formed. Asterisks indicate TGFβ3-negative, α-SMA-negative endothelial
e bar=100 μm.
Fig. 11. AVendocardial/myocardial co-culture treated with dnBMPR-1B or caBMPR-1B was double immunostained with a RCAS viral marker, AMV3c2 (A and D)
and anti-TGFβ3 (B and E). Panels C and F are merged images of panels A and B, and panels D and E, respectively. The majority of dnBMPR-1B-infected endocardial
cells remained as TGFβ3-negative epithelial cells (arrowheads in panels A–C). Only a few dnBMPR-1B-infected endocardial cells became mesenchymal and
expressed TGFβ3 (arrows in panels A–C). In contrast, the majority of caBMPR-1B-infected cells became TGFβ3-positive mesenchymal cells (arrows in panels D–F).
Note that a few caBMPR-1B-infected cells remained as epithelial cells but expressed TGFβ3 (arrowheads in panels D–F). Scale bar=100 μm.
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cushion tissue
The dnBMPR-1B or caBMPR-1B virus was microinjected
into cardiac jelly near the endocardial side of the AV canal in
chick embryos in ovo at stage-13 when endocardial cells had
not yet transformed. Eggs were incubated for an additional two
days. Virus-infected cells were detected by a viral marker,
AMV3c2 immunohistochemistry, and confocal microscopy.
The majority of the cells that had been infected with dnBMPR-
1B remained at or near the luminal surface of the AV cushion as
epithelial cells (Figs. 13A–C and 14), whereas most of the
caBMPR-1B-infected cells transformed into mesenchymal cells
and invaded deeply into AV cushion (Figs. 13D–F and 14). It is
important to note that, in some representative cases, while
cushion mesenchyme was formed, all of the AMV3c2-positive
dnBMPR-1B-infected cells remained as endocardial epithelial
cells (Fig. 13).
Discussion
A dominant-negative approach can circumvent functional
redundancies among Type I BMP receptors in chick AV EMT
Our present study indicated that dnBMPR-1B infection or
noggin treatment of AV endocardium significantly reduced
EMT whereas caBMPR-1B infection enhanced EMT from AV
endocardium in the presence of BMP-2 or associated AV
myocardium in chick AV culture (Figs. 2, 5 and 15). Moreover,
our microinjection study revealed that dnBMPR-1B virus-
infected cells remained in the endocardial epithelium, whereas
caBMPR-1B-infected cells invaded deeper into the cushion asmesenchyme in vivo (ovo) (Fig. 13). These data provided
evidence that BMP signaling through endocardial endothelial
cells was required in AV EMT and active BMPR-1B in the
endocardial cells could induce AV EMT. However, our data do
not exclude the possibilities that other BMP receptors in the
endocardium are involved in BMP-supported AV EMT, since
dominantly expressed mutant BMPR-1B can block signal
transduction through any probable BMP receptor. For example,
the chick activin type I receptor (ALK2) was implicated in AV
mesenchymal cell formation/migration by the study in which
neutralizing antibodies to chALK2 were used in chick AV
explants (Lai et al., 2000). Furthermore, active ALK2 was
reported to induce ventricular endocardial cells to undergo EMT
in the chick (Desgrosellier et al., 2005).
More recently, functional redundancies among endocardially
expressed type I BMP receptors have been suggested by the
studies in which ALK3 (BMPR-1A) or ALK2 was conditionally
deleted from endothelium in mice (Ma et al., 2005; Wang et al.,
2005; Park et al., 2006; Song et al., 2007). ALK2 can bind other
TGFβ superfamily, TGFβs and Activin in addition to BMPs;
however ALK3 transmits BMP signaling exclusively (de
Caestecker, 2004). Regardless of the differences in ligand
specificities, mutant mice with ALK2 and ALK3 conditional
ablation from the endothelial cells displayed defects in AV septa
and valves, which appeared to result from a failure of
endocardial EMT. Although ALK3 conditional deletion from
the endothelium produced a severe deficiency, neither ALK2
nor ALK3 conditional deletion showed complete disruption of
EMT, despite the fact that the BMP-2 conditional deletion from
the myocardium completely disrupted AV EMT (Ma et al.,
2005; Rivera-Feliciano and Tabin, 2006). In fact, one-third of
the ALK3 conditional deletion mutants were reported to form
Fig. 12. Quantitative evaluation of AMV3c2 and anti-TGFβ3 double immuno-
stained AV endocardial/myocardial co-culture treated with dnBMPR-1B or
caBMPR-1B (Fig. 11). The data represent the average of TGFβ3 immunostaining
intensity from multiple AMV3c2 positive endocardial epithelial cells or
mesenchymal cells. The average immunointensity of endocardial epithelial
cells in the explants cultured with M199 alone was determined as 100% intensity
as control. Immunointensity of dnBMPR-1B infected endocardial epithelial cells
was weaker than control (*p<0.04 by Student's t-test), whereas, immunointen-
sity of caBMPR-1B infected endocardial epithelial cells was stronger than
control (**p<0.0001 by Student's t-test). There was no significant difference in
TGFβ3 immunointensity of mesenchymal cells within explants treated with
dnBMPR-1B, caBMPR-1B or M199 alone. Number of the explants evaluated for
each treatment: 15 for dnBMPR-1B, 13 for caBMPR-1B and 5 for M199 alone.
N=number of cells evaluated for immunointensity.
Fig. 13. Microinjection study of dnBMPR-1B and caBMPR-1B into AV cushion
tissue. dnBMPR-1B (A–C) or caBMPR-1B (D–F) virus was microinjected into
cardiac jelly near the endocardial side of AV canal in chick embryos at stage-13
when endocardial cells had not transformed yet in ovo. Eggs were resealed and
incubated for an additional two days. Virus-infected cells (green) were detected
by AMV3c2 immunohistochemistry and confocal microscopy (A–E). Panels B
and E represent higher power views of panels A and D respectively. Panels C
and F are 5-μm sections of the AV canal of chick embryos and represent a typical
case after virus microinjection. The majority of dnBMPR-1B-infected cells
stayed at or near the luminal surface of the AV cushion as epithelial cells (arrows
in panels A–C), whereas most of caBMPR-1B-infected cells transformed into
mesenchymal cells and invaded deeper into AV cushion (arrows in panels D–F).
The green color in the myocardium in panels A and D is autofluorescence
caused by stacking images by confocal microscopy. In panel C (a representative
section of AV canal from a dnBMPR-1B-treated embryo), most of the
endocardial epithelial cells are AMV3c2-positive, whereas many AV cushion
mesenchymal cells are AMV3c2-negative. Since 100% of virus infection cannot
be achieved, these viral marker-negative mesenchymal cells are presumably
endocardially derived cells that escaped from virus infection or cells which have
different origins. a, atrium; v, ventricle; av, atrioventricular canal; o, outflow
tract; e, endocardial epithelial cell; m, myocardium. Scale bar in panel
A=100 μm for (A and D). Scale bar in panel B=100 μm for (B, E, C, and F).
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could result from variability of cre activity; however, it is
possible that the Type I BMP receptor in the endocardium have
functional redundancies for AV EMT. This view is consistent
with the findings that BMPR-1B is required for chondrogenesis
in the limb (Baur et al., 2000; Yi et al., 2000), where BMPR-1B
is the only Type I BMP receptor that transmits BMP signaling in
chondrocytes (Abe, 2006) but not for endocardial EMT in the
cardiac AV cushion, where multiple BMP receptors are
expressed in the endocardial cells. In the present study,
dnBMPR-1B infection of endocardium disrupted AV EMT
both in the AV explant cultures in vitro and whole-embryo
cultures in vivo (ovo). The discrepancy between BMPR-1B
knockout data in the mouse and our data from dnBMPR-1B-
virus infection in the chick may reflect the functional difference
in endocardial BMP receptors between the two species.
Nevertheless, the significance of our dominant-negative
approach is that it does effectively demonstrate unequivocally
the necessity for BMP signaling in AV endocardial cells during
AV cushion tissue formation.
TGFβ expression in AV endocardium can be regulated by BMP
signaling
TGFβs (Potts and Runyan, 1989; Potts et al., 1991;
Nakajima et al., 1994, 1998; Ramsdell and Markwald, 1997;
Boyer et al., 1999a; Camenisch et al., 2002) and their receptors
(Brown et al., 1996, 1999; Boyer et al., 1999b; Lai et al., 2000;Boyer and Runyan, 2001; Desgrosellier et al., 2005) are well-
documented factors implicated in AV cushion mesenchymal cell
formation and migration in the chick. AV endocardial epithelial
cells in the chick, upon activation by myocardial signaling,
appear to express TGFβ3 as part of an in vivo autocrine
mechanism for regulating and sustaining the transformation
from endocardial to mesenchymal phenotype (Nakajima et al.,
1994, 1998; Ramsdell and Markwald, 1997). While upregula-
tion of TGFβ3 in the endocardial endothelial cells is critical for
Fig. 14. Quantitative evaluation of mesenchymal cell formation in the AV canal
microinjected with dnBMPR-1B or caBMPR-1B virus (Fig. 13). Embryos were
scored positive in mesenchymal cell formation when AMV3c2-positive cells
were found in cushion mesenchyme but were scored negative when AMV3c2-
positive cells were found only in endocardial epithelium. These results indicate a
tendency of dnBMPR-1B-infected cells to remain as endocardial epithelial cells
whereas caBMPR-1B-infected cells transform into mesenchymal cells.
N=number of embryos evaluated.
190 H. Okagawa et al. / Developmental Biology 306 (2007) 179–192AV EMT in the chick, the factor from the AV myocardium that
regulates TGFβ3 expression in AV endocardial cells has not
been determined.
Therefore, in the present study, we sought to determine the
interactions between BMP signaling and endocardially
expressed TGFβ3 in AV EMT. Data from our in vitro culture
assays indicated that dnBMPR-1B infection significantly
reduced TGFβ3 expression in AV endocardial endothelial
cells, whereas caBMPR-1B-infection enhanced TGFβ3-expres-
sion even if caBMPR-1B-infected endocardial cells remained
on the surface of the collagen gels in culture in the presence ofFig. 15. Inhibition and enhancement of mesenchymal cell formation by dnBMPR-1
100% in co-cultured explants, non-infected cells can transform into mesenchymal ce
formation is affected by the types of the virus (dn- vs. ca-BMPR-1B) infected the enAV myocardium or BMP-2 (Figs. 11 and 12). Thus, activation
of BMPR appeared to correlate with an upregulation of TGFβ3
expression in endocardial endothelial cells, which supports the
idea that BMP ligands secreted by the myocardium regulate
TGFβ3-expression in the endocardial cells via BMP pathways
in AVendocardial cells during EMT. Secretion of TGFβ3 in the
endocardial cells, in turn, would enhance AV endocardial EMT
and migration of the endocardial cells as described (Nakajima et
al., 1994, 1998; Ramsdell and Markwald, 1997). Our previous
report (Sugi et al., 2004) also indicated that BMP-2 induced
TGFβ2 expression in AVendocardial cells in mouse AVexplant
culture, in which TGFβ2 appears to be an endocardial
activation marker as reported by Camenisch et al. (2002). Our
results are consistent with the recent mouse data obtained by the
conditional deletion of BMP-2 using the Nkx2.5-cre system
which displays defects in AV endocardial EMT along with
downregulation of TGFβ2 in the AV endocardium (Ma et al.,
2005). Although BMP signaling in the myocardium can also
regulate myocardial TGFβ2 expression as evident in the Alk3
conditional knockout (Gaussin et al., 2002, 2005), it is clear that
interactions of BMP signaling and TGFβ transcriptional
regulation in the endocardial cells during AV EMT appear to
be critical for completion of EMT and remain to be elucidated.
BMP signaling through AV endocardial cells is essential for
activation of AV endocardial cells in the chick
Although some cushion mesenchyme is formed in TGFβ2
knockout mice (Sanford et al., 1997; Bartram et al., 2001),
TGFβ2 is highly expressed in AV myocardium at the onset of
AV EMT in mice and TGFβ2, but not TGFβ3, appears to be
required for AV EMT in mouse culture assays (Camenisch et al.,
2002). However, chick TGFβ2 expression is not restricted toB or caBMPR-1B was schematically illustrated. Since viral infection cannot be
lls regardless of viral treatment. However, the total amount of mesenchymal cell
docardial cells.
191H. Okagawa et al. / Developmental Biology 306 (2007) 179–192AV myocardium but expressed in both AV endocardium and
myocardium before and during EMT and both TGFβ2 and
TGFβ3 appear to be necessary for the full morphogenetic
programs of EMT in the chick (Boyer et al., 1999a; Camenisch
et al., 2002; Molin et al., 2003). These data suggest substantial
interspecies differences for TGFβ signaling between the chick
and the mouse in the distinct temporal events during AV EMT.
Regarding BMP signaling, BMP-2 expression is restricted to
the AV canal myocardium coincident with AV EMT in both the
chick (Yamagishi et al., 1999; Yamada et al., 1999; Somi et al.,
2004) and the mouse (Lyons et al., 1990; Sugi et al., 2004; Ma et
al., 2005; Rivera-Feliciano and Tabin, 2006). In our assays
using chick AV explants, recombinant human noggin or
dnBMPR-1B disrupted cell–cell separation, an initial step of
EMT when the AV endocardial epithelium was induced by
BMP-2 or associated myocardium (Figs. 2 and 5). Furthermore,
our data revealed that BMP-2 added to the AV endocardial
monolayer upregulated TGFβ3 and α-SMA-expression, which
are activation markers of AV EMT in the chick (Figs. 10 and
11). Therefore, consistent with our previous proposal in mice
(Sugi et al., 2004), BMP signaling in endocardial cells likely
regulates activation of endocardial cells to transform them into
cushion mesenchymal cells before TGFβ-signaling takes place
in AV EMT in the chick. This appears to be consistent with the
recent data from TGFβR2/Tie2cre mice (Jiao et al., 2006). Our
current work using RCAS-viral gene transfer to activate or
inactivate BMP receptor function in the endocardium in vitro
and in vivo (ovo) has provided evidence that BMP signaling
through the endocardium was essential for AV EMT in the
chick. Our data further support the proposal that myocardial
BMP-2 directly affects AV endocardium through a paracrine
pathway that is essential for EMT and that activation of BMP
receptors in endocardial cells induces AV EMT.
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